ribocytokine il-2 bnt151
Generic: Ribocytokine IL-2 BNT151
ribocytokine il-2 bnt151: 1 clinical trial tracked.
ribocytokine il-2 bnt151 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about ribocytokine il-2 bnt151, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
Phase I/IIa, First-in-human, Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors
Primary endpoint: Number of Participants With Dose Limiting Toxicities (DLTs) During the DLT Evaluation Period in Part 1
Interventionalopen49 targetStarted 2021-01Completion 2024-056 sites · Spain, United StatesBioNTech SE